RxDoctor Payments Data

Howard Lantner, MD

Neurosurgery · Hartford, CTNPI 1730127382

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $145,451 of the $150,642 with a category attached, or 96.6%. Globus Medical accounts for 96.6% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $48,236 and has fallen 96.4% since, to $1,748 in 2025.

$150,642in general payments, 2019–2025

Across 50 payments — averaging $3012.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$145K
  • Stryker$3K
  • 4web, Inc.$1K
  • Johnson & Johnson$506
  • Cerapedics Inc.$350
  • Zimvie Inc.$33
  • plus $45 from 2 others
$91,345in research payments, 2019–2025

Across 3 payments — averaging $30,448 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Cerapedics Inc.$91K

What the payments were for

  • Royalty or licence$145,45197%
  • Consulting fees$1,0001%
  • Travel & lodging$2,4032%
  • Food & beverage$1,7881%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few neurosurgery providers in Connecticutto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$96,276
Medicare patients
141
Services billed
329

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurosurgery in Hartford

Where these figures come from

Is this you, or does something look wrong? →